Announcements Trials
Browse Landscape

Clinical Trials

4 trials
RecentStart dateEnrollment
ESCC × Clear all

Phase

Phase NA 2Phase 2 1Phase 1/2 1

Status

Unknown 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 13011Neoplasms 10392Carcinoma, Non-Small-Cell Lung 6808Prostatic Neoplasms 6205Colorectal Neoplasms 5873Lung Neoplasms 5047Multiple Myeloma 3545Pancreatic Neoplasms 3516Neoplasm Metastasis 3482Leukemia, Myeloid, Acute 3471Carcinoma, Hepatocellular 3235Ovarian Neoplasms 3144Melanoma 3120Stomach Neoplasms 3024Lymphoma 2971Head and Neck Neoplasms 2576Recurrence 2532Precursor Cell Lymphoblastic Leukemia-Lymphoma 2486Leukemia 2354Colonic Neoplasms 2320Brain Neoplasms 2296Lymphoma, Non-Hodgkin 2259Rectal Neoplasms 2174Uterine Cervical Neoplasms 2168Glioblastoma 1997Leukemia, Lymphocytic, Chronic, B-Cell 1985Carcinoma, Renal Cell 1898Squamous Cell Carcinoma of Head and Neck 1859Lymphoma, Follicular 1831Esophageal Neoplasms 1785

Interventions

trifluridine tipiracil drug combination 1camrelizumab 1anlotinib 1Radiotherapy 1Induction Chemotherapy 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT07196345 2025-09-29

TAS-102 Plus Radiotherapy in Elderly ESCC

Qianfoshan Hospital

Phase 1/2 Not yet recruiting
45 enrolled

ESCC

NCT07015489 2025-06-11

Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal Cancer

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Completed
44 enrolled

ESCC

NCT05050760 2023-01-31

DCF Combined With Camrelizumab in the Treatment of Esophageal Cancer

Xijing Hospital

Phase NA Unknown
55 enrolled

ESCC

NCT04471480 2020-07-15

TC

Third Military Medical University

Phase NA Unknown
90 enrolled

ESCC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡